ACM
DNTH icon

Aquatic Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Aquatic Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
+24,234
New +$2.12M 0.08% 321
2026
Q1 		– Sell
-16,829
Closed -$694K – 1477
2025
Q4 		$694K Buy
+16,829
New +$652K 0.02% 645
2025
Q3 		– Sell
-3,187
Closed -$59.4K – 1454
2025
Q2 		$59.4K Buy
+3,187
New +$59.8K ﹤0.01% 1131

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Aquatic Capital Management's DNTH Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 24,234 shares worth $2.36M. The stake represents 0.08% of the portfolio and ranks #321 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in DNTH as recently as Q4 2025.

Aquatic Capital Management first reported a position in DNTH in Q2 2025 and has held it in 3 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Aquatic Capital Management held 24,234 shares of Dianthus Therapeutics worth $2.36M as of Q2 2026.
  • Dianthus Therapeutics was a new Aquatic Capital Management position in Q2 2026.
  • Dianthus Therapeutics made up 0.08% of Aquatic Capital Management's portfolio in Q2 2026, its #321 holding.
  • Aquatic Capital Management first reported a position in Dianthus Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.